Greg Conley Email

VP, Business and Alliance Management . Anokion

Current Roles

Employees:
39
Revenue:
$3M
About
Anokion, a spin-off from the Ecole Polytechnique Fédérale de Lausanne (EPFL), is focused on applying the company?s antigen-specific immune tolerance technology to reduce the immunogenicity of therapeutic proteins and to treat autoimmune and allergic diseases. As a platform technology, Anokion?s approach to antigen-specific tolerance can be translated to virtually any protein in numerous clinical indications. www.anokion.com
Anokion Address
50 Hampshire Street
Cambridge, MA
United States
Anokion Email

Past Companies

AnokionVice President, Business and Alliance Management
AnokionVice President of Therapeutic Research and Development
Kanyos BioSenior Director, Therapeutic Research Sciences

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.